The University of Chicago Header Logo

Connection

Mark Talamonti to Etanercept

Back to Details
This is a "connection" page, showing publications Mark Talamonti has written about Etanercept.
Mark Talamonti
Connection Strength
0.178
Etanercept
  1. Psoriasis Area and Severity Index response in moderate-severe psoriatic patients switched to adalimumab: results from the OPPSA study. J Eur Acad Dermatol Venereol. 2018 Oct; 32(10):1737-1744.
    View in: PubMed
    Score: 0.157
  2. Efficacy of efalizumab in psoriasis patients previously treated with tumour necrosis factor blockers. Dermatology. 2009; 219(1):48-53.
    View in: PubMed
    Score: 0.021
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.